Is Krishna Institute of Medical Sciences Ltd debt-free?

Yes, Krishna Institute of Medical Sciences Ltd is debt-free with a debt-to-equity ratio of 0.33.

Home

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd Financials

Krishna Institute of Medical Sciences Ltd Financial Statement

Krishna Institute of Medical Sciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Mar 2025	Dec 2024	Sep 2024
Revenue	380.90	368.10	369.90
Operating Expense	237.20	244.60	252.20
Net Profit	93.50	76.50	72.20
Net Profit Margin	24.55	20.78	19.52
Earning Per Share	2.34	1.91	1.80
EBIDTA	137.10	121.70	120.10
Effective Tax Rate	14.20	19.11	24.89

Particulars	Mar 2025
Revenue	380.90
Operating Expense	237.20
Net Profit	93.50
Net Profit Margin	24.55
Earning Per Share	2.34
EBIDTA	137.10
Effective Tax Rate	14.20

Krishna Institute of Medical Sciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	1,222.05	1,132.02	1,143.38
Operating Expenses Annual	857.65	771.74	747.16
Operating Profit Annual	379.94	383.78	420.39
Interest Annual	3.66	1.15	4.47
Depreciation	53.31	41.94	42.90
Net Profit Annual	235.34	252.49	278.37
Tax Annual	82.83	84.84	92.64

Particulars	Mar 2024
Total Revenue Annual	1,222.05
Operating Expenses Annual	857.65
Operating Profit Annual	379.94
Interest Annual	3.66
Depreciation	53.31
Net Profit Annual	235.34
Tax Annual	82.83

Krishna Institute of Medical Sciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	38.10	19.86	34.59
Cash Flow from Operations	262.39	271.05	284.37
Cash Flow from Investing	-568.65	-237.67	-375.08
Cash Flow from Financing	288.64	-15.14	75.98
Cash Flow at the End	20.48	38.10	19.86

Particulars	Mar 2024
Cash Flow at the Beginning	38.10
Cash Flow from Operations	262.39
Cash Flow from Investing	-568.65
Cash Flow from Financing	288.64
Cash Flow at the End	20.48

Krishna Institute of Medical Sciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	31.40	34.22	37.16
PBIT Margin (%)	26.65	30.22	33.23
PBT Margin (%)	23.09	23.92	29.50
Net PROFIT Margin (%)	19.26	22.30	24.35
Return On Networth / Equity (%)	13.46	16.79	24.15
Return On Networth /Employed (%)	16.77	22.23	30.50
Return On Assets (%)	12.13	16.51	22.64
Total Debt / Equity (X)	0.09	0.01	0.07
Asset Turnover Ratio (%)	0.63	0.74	0.93

Particulars	Mar 2024
PBDIT Margin (%)	31.40
PBIT Margin (%)	26.65
PBT Margin (%)	23.09
Net PROFIT Margin (%)	19.26
Return On Networth / Equity (%)	13.46
Return On Networth /Employed (%)	16.77
Return On Assets (%)	12.13
Total Debt / Equity (X)	0.09
Asset Turnover Ratio (%)	0.63

Krishna Institute of Medical Sciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	673.92	612.28	591.97
Total Current Assets Annual	301.17	237.04	331.28
Non Current Assets Annual	2,095.34	1,575.02	1,237.50
Total Shareholders Funds Annual	1,866.45	1,630.86	1,377.55
Total Assets Annual	2,396.51	1,812.07	1,568.78

Particulars	Mar 2024
Fixed Assets Annual	673.92
Total Current Assets Annual	301.17
Non Current Assets Annual	2,095.34
Total Shareholders Funds Annual	1,866.45
Total Assets Annual	2,396.51

Krishna Institute of Medical Sciences Ltd Earning Calls

EPS (INR)

Expected

2.55

Reported

2.54

Surprise

-0.39%

Dec 2024

EPS beaten by -0.39%

Sep 2024

EPS beaten by 0.00%

Jun 2024

EPS beaten by -0.37%

Dividend Pages

PE Ratio

FAQS on Krishna Institute of Medical Sciences Ltd Financials

As of Jun 28, 2025, Krishna Institute of Medical Sciences Ltd has a market capitalization of 25,580.88 Cr. Value Research classifies it as a Large-Cap company.

Yes, Krishna Institute of Medical Sciences Ltd is with a debt-to-equity ratio of 0.33.

In FY 2024 , Krishna Institute of Medical Sciences Ltd recorded a total revenue of approximately 1,384.10 Cr marking a significant milestone in the company's financial performance.

Krishna Institute of Medical Sciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.1% annually, respectively..

Krishna Institute of Medical Sciences Ltd's current PE ratio is 84.45.

Krishna Institute of Medical Sciences Ltd's ROCE averaged 16.6% from the FY ending March 2023 to 2025, with a median of 14.7%. It peaked at 20.6% in March 2023, reflecting strong capital efficiency over the period..

Krishna Institute of Medical Sciences Ltd's latest EBIT is Rs. 426.30 Cr, surpassing the average EBIT of Rs. 362.19 Cr over the 5 years..